Antitumor Research Reagents (for Experimental Use) — compiles compounds studied for their role in cell proliferation and cancer-related signaling pathways, including DNA alkylating agents, kinase inhibitors, and proteasome inhibitors, used as experimental models in molecular oncology research. This category brings together various structural frameworks with diverse biological targets.
Antitumor Research Reagents (for Experimental Use) are used by molecular biology and pharmacology researchers as in vitro test materials in cell cultures to investigate signaling pathways, gene expression, and mechanisms of proliferation inhibition. Compounds such as tyrosine kinase inhibitors and proteasome inhibitors in this category also serve as reference compounds in the development of screening assays and structure-activity relationship studies.
Example products in this collection: TCI I0747 99011-02-6 Imiquimod, TCI B5520 714971-09-2 BMS-599626, TCI A0410 54-62-6 Aminopterin, TCI B5630 292605-14-2 SB-3CT, TCI I0906 152459-95-5 Imatinib, TCI B5707 96187-53-0 Brequinar, TCI Z0022 3690-10-6 Zebularine, TCI B5741 179324-69-7 Bortezomib.
Pay attention to analytical purity, storage conditions (low temperature, protected from light) for unstable compounds, and salt or hydrate forms that affect solubility in test media. All products are genuine Tokyo Chemical Industry (TCI) Japan products, with purity, packaging, and storage conditions listed on each item's page.
Other categories parallel under Pharmaceutical Research Reagents (for Experimental Use), often used together in one laboratory workflow:
This collection is further divided into 1 more specific group:
Back to Pharmaceutical Research Reagents (for Experimental Use). For large-volume procurement, special packaging, or specific grades, contact the AMI Scientific team — official distributor of TCI Japan in Indonesia — for availability checks and lead times directly from Japan.
